El Salvador vs Nicaragua: Expected share of deaths from non-communicable diseases
El Salvador
12.6%
in 2021
Nicaragua
12.6%
in 2021
El Salvador rank
142nd
Nicaragua rank
142nd
Expected share of deaths from non-communicable diseases over time
- El Salvador
- Nicaragua
How they compare
El Salvador currently reports 12.6% against 12.6% in Nicaragua, a difference of 0.0%.
The two have swapped places 6 times across 22 shared years of data; in 2000 it was Nicaragua ahead.
El Salvador ranks 142nd and Nicaragua ranks 142nd of 185 countries.
Across the 3 decades both report, El Salvador averaged higher in 1 and Nicaragua in 2.
Head to head by decade
| Decade | El Salvador | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.2% | 14.1% | 1.8% | Nicaragua |
| 2010s | 12.7% | 13.5% | 0.9% | Nicaragua |
| 2020s | 12.8% | 12.5% | 0.3% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected share of deaths from non-communicable diseases, El Salvador or Nicaragua?
- El Salvador, at 12.6% against 12.6% in Nicaragua as of 2021.
- What is the difference in expected share of deaths from non-communicable diseases between El Salvador and Nicaragua?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Nicaragua?
- 22 years are reported by both, from 2000 to 2021.
- How do El Salvador and Nicaragua rank globally for expected share of deaths from non-communicable diseases?
- El Salvador ranks 142nd and Nicaragua ranks 142nd of 185 countries.
- Where does this data come from?
- World Health Organization (WHO), Global Health Observatory, via World Bank (2026) – processed by Our World in Data, published as Expected share of deaths from non-communicable diseases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.